CHANGE OF PLATELETS IN PATIENTS UNDERGOING ECMO
Main Article Content
Abstract
Study objectives: Describe the prevalence, severity, and course of platelets in ECMO patients in the intensive care center. Study subjects: 39 ECMO patients at Bach Mai Hospital's Intensive Care Center from September 2021 to July 2022. Methods: This is a descriptive study. Results: Thrombocytopenia was observed in 39/39 (100%) ECMO patients in the intensive care center, in which the average day of onset of thrombocytopenia was 1.7±0.8 days. Conclusion: Thrombocytopenia is common in ECMO patients, regardless of the type of ECMO mode. Thrombocytopenia is related to ECMO duration. The underlying mechanisms are multifactorial, and understanding and management are still limited. Further research to design appropriate strategies and protocols for its monitoring, management, or prevention should be a matter of thorough investigations.
Article Details
Keywords
Thrombocytopenia, intensive care unit, ECMO
References
2. Abrams D, Baldwin MR, Champion M, et al. Thrombocytopenia and extracorporeal membrane oxygenation in adults with acute respiratory failure: a cohort study. Intensive Care Med. 2016; 42(5):844-852. doi:10.1007/s00134-016-4312-9
3. Sokolovic M, Pratt AK, Vukicevic V, Sarumi M, Johnson LS, Shah NS. Platelet Count Trends and Prevalence of Heparin-Induced Thrombocytopenia in a Cohort of Extracorporeal Membrane Oxygenator Patients. Crit Care Med. 2016;44(11):e1031-e1037. doi:10.1097/CCM.0000000000001869
4. Jiritano F, Serraino GF, ten Cate H, et al. Platelets and extra-corporeal membrane oxygenation in adult patients: a systematic review and meta-analysis. Intensive Care Med. 2020;46(6):1154-1169. doi:10.1007/s00134-020-06031-4
5. Williamson DR, Lesur O, Tétrault JP, Nault V, Pilon D. Thrombocytopenia in the critically ill: prevalence, incidence, risk factors, and clinical outcomes. Can J Anaesth J Can Anesth. 2013; 60(7):641-651. doi:10.1007/s12630-013-9933-7
6. Smith A, Hardison D, Bridges B, Pietsch J. Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation. Perfusion. 2013; 28(1):54-60. doi:10.1177/0267659112457969
7. Aubron C, DePuydt J, Belon F, et al. Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation. Ann Intensive Care. 2016;6(1):97. doi:10.1186/ s13613-016-0196-7
8. Nguyễn Văn Trọng. Khảo sát một số rối loạn đông cầm máu ở bệnh nhân được điều trị bằng kỹ thuật tim phổi nhân tạo. Luận văn thạc sĩ Y học 2019, Trường Đại học y Hà Nội
9. Phạm Đăng Thuần. Nhận xét hiệu quả phác đồ chống đông bằng heparin trong ký thuật tim phổi nhân tạo tại giường. Luận văn thạc sĩ Y học 2016, Trường Đại học y Hà Nội
10. Malfertheiner MV, Philipp A, Lubnow M, et al. Hemostatic Changes During Extracorporeal Membrane Oxygenation: A Prospective Randomized Clinical Trial Comparing Three Different Extracorporeal Membrane Oxygenation Systems. Crit Care Med. 2016;44(4):747-754. doi:10.1097/CCM.0000000000001482
11. Lukito P, Wong A, Jing J, et al. Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI. J Thromb Haemost JTH. 2016;14(11):2253-2260. doi:10.1111/jth.13497